Institute of Orthopedics, The First Medical Center, Chinese PLA General Hospital, Beijing Key Lab of Regenerative Medicine in Orthopedics, Key Laboratory of Musculoskeletal Trauma and War Injuries PLA, No. 28 Fuxing Road, Haidian District, Beijing 100853, China; School of Medicine, Nankai University, Tianjin 300071, China.
Institute of Orthopedics, The First Medical Center, Chinese PLA General Hospital, Beijing Key Lab of Regenerative Medicine in Orthopedics, Key Laboratory of Musculoskeletal Trauma and War Injuries PLA, No. 28 Fuxing Road, Haidian District, Beijing 100853, China.
Acta Biomater. 2021 Jun;127:131-145. doi: 10.1016/j.actbio.2021.03.054. Epub 2021 Mar 31.
Cartilage regeneration is a complex physiological process. Synovial macrophages play a critical immunomodulatory role in the acute inflammatory response surrounding joint injury. Due to the contrasting differences and heterogeneity of macrophage, the phenotype of macrophages are the key determinants of the healing response after cartilage injury. Biomaterials derived from extracellular matrix have been used for the repair and reconstruction of a variety of tissues by modulating the host macrophage response. However, the immunomodulatory effect of decellularized cartilage extracellular matrix (ECM) on macrophages has not been elucidated. It is necessary to clarify the immunomodulatory properties of decellularized cartilage matrix (DCM) to guide the design of cartilage regeneration materials. Here, we prepared porcine articular cartilage derived DCM and determined the response of mouse bone marrow-derived macrophages (BMDMs) to the pepsin-solubilized DCM (PDCM) in vitro. Macrophages activated by the PDCM could promote bone marrow-derived mesenchymal stem cells (BMSCs) invasion, migration, proliferation, and chondrogenic differentiation. Then, we verified that early optimization of the immunomodulatory effects of the cell-free DCM scaffold using IL-4 in vivo could achieve good cartilage regeneration in a rat knee osteochondral defect model. Therefore, this decellularized cartilage ECM scaffold combined with accurate and active immunomodulatory strategies provides a new approach for the development of cartilage regeneration materials. STATEMENT OF SIGNIFICANCE: This work reports a decellularized cartilage extracellular matrix (DCM) scaffold combined with an accurate and active immunomodulatory strategy to improve cartilage regeneration. Our findings demonstrated that the pepsin-solubilized DCM (PDCM) activated bone marrow-derived macrophages to polarize to a constructive macrophage phenotype. These polarized macrophages promoted bone marrow-derived mesenchymal stem cell invasion, migration, proliferation, and chondrogenic differentiation. DCM scaffolds combined with early-stage intra-articular injection of IL-4 created a wound-healing microenvironment and improved cartilage regeneration in a rat knee osteochondral defect model.
软骨再生是一个复杂的生理过程。滑膜巨噬细胞在关节损伤周围的急性炎症反应中发挥着关键的免疫调节作用。由于巨噬细胞的对比差异和异质性,巨噬细胞的表型是软骨损伤后修复反应的关键决定因素。源自细胞外基质的生物材料已被用于通过调节宿主巨噬细胞反应来修复和重建各种组织。然而,脱细胞软骨细胞外基质(DCM)对巨噬细胞的免疫调节作用尚未阐明。有必要阐明脱细胞软骨基质(DCM)的免疫调节特性,以指导软骨再生材料的设计。在这里,我们制备了猪关节软骨衍生的 DCM,并确定了体外小鼠骨髓来源的巨噬细胞(BMDM)对胃蛋白酶溶解的 DCM(PDCM)的反应。PDCM 激活的巨噬细胞可以促进骨髓间充质干细胞(BMSC)的侵袭、迁移、增殖和软骨分化。然后,我们验证了体内使用 IL-4 对无细胞 DCM 支架的免疫调节作用进行早期优化可以在大鼠膝关节骨软骨缺损模型中实现良好的软骨再生。因此,这种脱细胞软骨细胞外基质支架结合准确和主动的免疫调节策略为软骨再生材料的开发提供了一种新方法。
这项工作报道了一种脱细胞软骨细胞外基质(DCM)支架结合准确和主动的免疫调节策略,以改善软骨再生。我们的研究结果表明,胃蛋白酶溶解的 DCM(PDCM)激活骨髓来源的巨噬细胞向建设性的巨噬细胞表型极化。这些极化的巨噬细胞促进骨髓间充质干细胞的侵袭、迁移、增殖和软骨分化。DCM 支架结合早期关节内注射 IL-4 可创造一个伤口愈合的微环境,并改善大鼠膝关节骨软骨缺损模型中的软骨再生。